Vertex Pharmaceuticals to Participate in Citi’s Global Healthcare Conference

BOSTON, Nov. 19, 2025 — Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) announced today that key executives will participate in Citi’s 2025 Global Healthcare Conference.

Charlie Wagner, the Chief Operating and Financial Officer, and David Altshuler, the Chief Scientific Officer, are scheduled to take part in a fireside chat on Wednesday, December 3, 2025, at 9:00 a.m. ET.

A live webcast of their remarks will be accessible through Vertex’s website, specifically within the ‘Investors’ section under the ‘News and Events’ page. After the event, a replay of the conference webcast will also be archived on the company’s site.

Vertex Pharmaceuticals is a global biotechnology company that prioritizes scientific innovation to develop transformative medicines for patients with serious diseases. They have approved treatments for cystic fibrosis, sickle cell disease, and other urgent medical needs.

Founded in 1989, Vertex has its global headquarters in Boston, with additional offices in London and various sites across North America, Europe, and beyond. The company has been recognized consistently as a top workplace, including 16 years on Science magazine’s Top Employers list.

To stay updated on Vertex’s innovative efforts, visit their website or follow them on social media.